human clinical trials ongoing as of 2026 Search volume: 165,000 monthly US searches most searched non-weight-loss peptide Legal status: Category 1 compounding (legal under physician prescription, as of February 2026) Administration: Subcutaneous injection or oral/sublingual (gut applications) An honest note on the evidence: The majority of BPC-157 research has been conducted in animal models rats and mice primarily
A spontaneous alternation is made when an animal visit three different arms in three consecutive arm entries
You get some studies that were done on rats that injured their MCL, and they healed faster
Sierra A, Encinas JM, Deudero JJ, Chancey JH, Enikolopov G, Overstreet-Wadiche LS, Tsirka SE, Maletic-Savatic M
Every protocol is designed and prescribed by doctors licensed by the Medical Council of Thailand, as shown on our About Us page